North Carolina eVP #Doc2365935872

North Carolina DHHS RFI for Cloud-Based Controlled Substances Reporting System Solution

North Carolina's Department of Health and Human Services (DHHS), Division of Mental Health, Developmental Disabilities and Substance Use Services (DMH/DD/SUS), is seeking market information for a cloud-based Controlled Substances Reporting System (CSRS) solution to support the state's Prescription Drug Monitoring Program (PDMP). - Government Buyer: - North Carolina DHHS, Division of Mental Health, Developmental Disabilities and Substance Use Services - Solution Requirements: - Cloud-based, third-party hosted Software as a Service (SaaS) platform - Tracks dispensed prescriptions for Schedule II-V drugs and drugs of concern - Supports over 95,000 registered users statewide - Assists health professionals and regulatory bodies in identifying over prescribing, over dispensing, and drug diversion - Technical and Integration Needs: - Scalability to accommodate large user base - Integration with ASAP (American Society for Automation in Pharmacy) standards - Interoperability with National Association of Boards of Pharmacy PMP InterConnect and NC HealthConnex - Robust data ingestion, analytics, and reporting capabilities - 99.5% system availability and 24x7 helpdesk support - Compatibility with electronic health/medical record systems - Compliance Requirements: - Adherence to HIPAA, HITECH, 42 CFR Part 2, and GovRAMP standards - RFI Details: - No specific OEMs or vendors named; seeking information only - Respondents should address technical, operational, security, and financial aspects - This is not a solicitation for bids or a contract award

Description

The North Carolina Department of Health and Human Services (NC DHHS) is seeking information for a third-party hosted solution to support the Prescription Drug Monitoring Program (PDMP), known as the North Carolina Controlled Substances Reporting System (NC CSRS). The solution should track dispensed prescriptions for Schedule II-V drugs and drugs of concern, assist licensed health professionals in making informed pharmaceutical treatment decisions, and aid authorized regulatory bodies in identifying possible over prescribing, over dispensing, and drug diversion. This is a Request for Information (RFI) with no contractual obligation, and responses are due by September 21, 2026. The solution is expected to be cloud-based, scalable, compliant with various federal and state regulations, and capable of integrating with multiple systems and interfaces.

View original listing